
|Articles|February 19, 2016
Therapeutic Innovation & Regulatory Science: An Increasingly Global Approach
Author(s)DIA
Advertisement
After ten years of successive minority and/or majority Conservative leadership, Canada is now led by Prime Minister Justin Trudeau’s Liberal majority. A key component of the Liberal platform is the creation of a Chief Science Officer position to ensure that “scientific analyses are considered when the government makes decisions”; this renewed focus on evidence-based policy may be helpful to science-based industries across a number of sectors.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Why High-Risk Patients Still Need Antivirals: Q&A with Gurinder S. Sidhu, M.D.
2
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
3
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
4
A Patent Strategy Pharma Execs May Be Overlooking: Means-Plus-Function Claims
5




